| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Alan S. Roemer is Director at INAB. Alan S. Roemer's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $47K at current prices.
Net of sales, the INAB filings show accumulation of 26,315 shares.
Alan S. Roemer has 12 Form 4 filings on record from July 2021 to December 2025, all as Director at IN8BIO (INAB), 2021–2025.
The 23 reported transactions were 14 option or other derivative awards, 3 stock awards, 3 dispositions back to the company and 2 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $50K and no sales.
The only open-market purchase was 26,315 shares of INAB at an average $1.90 on August 16, 2022, about $50K. Twelve months later INAB was down 37%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | INAB In8bio, Inc. | Director | Buy | 26,315 | $1.90 | $49,998.50 | +88.7% | -19.6% | -37.0% |